Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Formosa Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Formosa Pharmaceuticals, founded in 2010, is a late-preclinical and early-clinical stage biopharmaceutical company with focus in the indications of ophthalmology, oncology, and anti-infectives. In August, 2017, Formosa Pharmaceuticals acquired Activus Pharmaceuticals (Funabashi, Japan), which afforded Formosa Pharmaceuticals a proprietary nanoparticle technology platform (APNT), and two late-stage preclinical assets in ophtha...
Formosa Pharmaceuticals, founded in 2010, is a late-preclinical and early-clinical stage biopharmaceutical company with focus in the indications of ophthalmology, oncology, and anti-infectives. In August, 2017, Formosa Pharmaceuticals acquired Activus Pharmaceuticals (Funabashi, Japan), which afforded Formosa Pharmaceuticals a proprietary nanoparticle technology platform (APNT), and two late-stage preclinical assets in ophthalmology. Of these ophthalmology candidates, APP13007 has just begun Phase 3 clinical trials in the United States for inflammation and pain after ocular surgery.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Formosa Pharmaceuticals
Taiwan Flag
Country
Country
Taiwan
Address
Address
8F-6, No.57, Fuxing N. Rd, Songshan Dist,Taipei City105
Telephone
Telephone
+886 2 2755-3023
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY